Business Context and Reporting Period
This Form 8-K Current Report was filed by Dominari Holdings Inc. (formerly AIkido Pharma Inc.) on December 22, 2022. The report documents a corporate name change and a corresponding change in the company's trading symbol on The Nasdaq Capital Market.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain financial statements or performance metrics.
Material Changes
- Corporate Name: Changed from "AIkido Pharma Inc." to "Dominari Holdings Inc." effective December 22, 2022.
- Trading Symbol: Changed from "AIKI" to "DOMH" effective with the opening of trading on December 22, 2022.
- Legal Documentation: An amendment to the Certificate of Incorporation was filed with the Secretary of State of Delaware to effectuate the name change.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, future outlook, management commentary on operations, specific risks, or contingencies. The document focuses solely on the administrative execution of the name and symbol change.
Investor Verification Checklist
- Verify the new trading symbol "DOMH" on The Nasdaq Capital Market.
- Confirm the legal name change to "Dominari Holdings Inc." in corporate registries.
- Review the press release (Exhibit 99.1) for strategic rationale behind the rebranding.
- Check subsequent filings for updated financial data under the new corporate identity.